The role of the human synovial fibroblast in monosodium urate crystal-induced synovitis

F. M. Wigley, I. T. Fine, D. S. Newcombe

Research output: Contribution to journalArticlepeer-review

Abstract

Human synovial fibroblasts (HSF) have been cultured to identify and quantitate arachidonate metabolites released after exposure to monosodium urate (MSU) crystals. These crystals caused a significant release of PGE2 and 6-keto-PGF1(α). Media lactate dehydrogenase levels from MSU-exposed HSF were equal to controls. Serum was required for the increase in metabolite release. Indomethacin and dexamethasone inhibited metabolite release, whereas colchicine increased metabolite release. MSU (1 mg/ml) released hydroxyeicosatetraenoic acids (HETE) from HSF whereas 20-fold higher doses were required to release these metabolites from human polymorphonuclear leukocytes. Colchicine increased but lipoxygenase inhibitors decreased HETE synthesis. Arachidonate, metabolites from HSF may contribute to the pathogenesis of crystal-provoked synovitides.

Original languageEnglish (US)
Pages (from-to)602-611
Number of pages10
JournalJournal of Rheumatology
Volume10
Issue number4
StatePublished - Dec 1 1983

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'The role of the human synovial fibroblast in monosodium urate crystal-induced synovitis'. Together they form a unique fingerprint.

Cite this